Dolby Laboratories (NYSE:DLB) reported Q3 EPS of $0.68, $0.33 better than the analyst estimate of $0.35. Revenue for the quarter came in at $289.6 million versus the consensus estimate of $295.65 million.
GUIDANCE:
Dolby Laboratories sees Q4 2022 EPS of $0.68-$0.83, versus the consensus of $0.87. Dolby Laboratories sees Q4 2022 revenue of $295-325 billion, versus the consensus of $326.8 billion.